PROACT: A randomised study comparing anastrozole with tamoxifen as neoadjuvant and adjuvant treatment in postmenopausal women with locally advanced breast cancer - a Japanese subgroup analysis

被引：0
|
作者：
Imoto, S. [1 ]
Takatsuka, Y. [2 ]
Fujiwara, Y. [3 ]
Inaji, H. [4 ]
Ikeda, T. [5 ]
Cataliotti, L. [6 ]
Buzdar, A. [7 ]
Noguchi, S. [8 ]
机构：
[1] Kyoto Univ Hosp, Sch Med, Tokyo, Japan
[2] Kansai Rosi Hosp, Dept Surg, Amagasaki, Hyogo, Japan
[3] Natl Canc Ctr, Tokyo, Japan
[4] Osaka Med Ctr Canc & Cardiovasc Dis, Res Inst, Osaka, Japan
[5] Teikyo Univ Hosp, Dept Surg, Tokyo, Japan
[6] Univ Florence, Clin Chirurg 1, Florence, Italy
[7] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
[8] Osaka Univ Hosp, Dept Breast & Endocrine Surg, Osaka 553, Japan
来源：
BREAST | 2009年 / 18卷
关键词：
D O I：
10.1016/S0960-9776(09)70204-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [1] Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial
    Kurosumi, Masafumi
    Takatsuka, Yuichi
    Watanabe, Toru
    Imoto, Shigeru
    Inaji, Hideo
    Tsuda, Hitoshi
    Akiyama, Futoshi
    Sakamoto, Goi
    Ikeda, Tadashi
    Noguchi, Shinzaburo
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (06) : 715 - 722
  • [2] Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial
    Masafumi Kurosumi
    Yuichi Takatsuka
    Toru Watanabe
    Shigeru Imoto
    Hideo Inaji
    Hitoshi Tsuda
    Futoshi Akiyama
    Goi Sakamoto
    Tadashi Ikeda
    Shinzaburo Noguchi
    [J]. Journal of Cancer Research and Clinical Oncology, 2008, 134 : 715 - 722
  • [3] Meta-analysis of trials comparing anastrozole and tamoxifen for adjuvant treatment of postmenopausal women with early breast cancer
    Aydiner, Adnan
    Tas, Faruk
    [J]. TRIALS, 2008, 9 (1)
  • [4] Meta-analysis of trials comparing anastrozole and tamoxifen for adjuvant treatment of postmenopausal women with early breast cancer
    Adnan Aydiner
    Faruk Tas
    [J]. Trials, 9
  • [5] Randomised study of anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women
    Vergote, I
    Bonneterre, J
    Thürlimann, B
    Robertson, J
    Krzakowski, M
    Mauriac, L
    Koralewski, L
    Webster, A
    Steinberg, M
    von Euler, M
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 : S84 - S85
  • [6] Anastrozole versus tamoxifen as neoadjuvant therapy for oestrogen receptor-positive breast cancer in postmenopausal women: the IMPACT and PROACT trials
    Smith, I.
    Cataliotti, L.
    [J]. EJC SUPPLEMENTS, 2004, 2 (03): : 69 - 70
  • [7] The effects of adjuvant anastrozole, exemestane, tamoxifen, and toremifene on serum lipids in postmenopausal women with breast cancer - a randomised study.
    Kataja, V
    Hietanen, P
    Joensuu, H
    Ala-Luhtala, T
    Asola, R
    Kokko, R
    Holli, K
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S156 - S156
  • [8] Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
    Baum, M
    Buzdar, AU
    Cuzick, J
    Forbes, J
    Houghton, J
    Klijn, JGM
    Sahmoud, T
    [J]. LANCET, 2002, 359 (9324): : 2131 - 2139
  • [9] Pharmacoeconomic aspects of adjuvant early breast cancer treatment in postmenopausal women with anastrozole or tamoxifen: a Slovenian perspective
    Piskur, R.
    Sonc, M.
    Cufer, T.
    Borstnar, S.
    Mrhar, A.
    [J]. EJC SUPPLEMENTS, 2004, 2 (03): : 75 - 75
  • [10] Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer
    Bago-Horvath, Zsuzsanna
    Rudas, Margaretha
    Dubsky, Peter
    Jakesz, Raimund
    Singer, Christian F.
    Kemmerling, Ralf
    Greil, Richard
    Jelen, Andrea
    Boehm, Gerhard
    Jasarevic, Zerina
    Haid, Anton
    Gruber, Christine
    Poestlberger, Sabine
    Filipits, Martin
    Gnant, Michael
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (24) : 7828 - 7834
12345